Non-response to anti-TNF therapy usually represents loss of disease control in patients with severe rheumatoid arthritis, as well as unnecessary exposure to potentially severe adverse effects of anti-TNF drugs and inefficient use of expansive biological therapeutics. The gene discussed is TNF; the disease is rheumatoid arthritis.